Primary Record
Pristinamycin IA
- In stock
- 8,485 g
- Purity
- 99.6 %
- CAS
- 3131-03-1
Compound Identifiers & Properties
- CAS
- 3131-03-1
- PubChem CID
- 11136668
- SMILES
- CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3CCC(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CC6=CC=C(C=C6)N(C)C)C
- Canonical SMILES
- CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O
Names & Synonyms
- Pristinamycin IA
- Streptogramin B
- Mikamycin B
- Ostreogrycin B
- Pristinamycin
- Mikamycin IA
- Virginiamycin B
- Pyostacine
- Vernamycin Balpha
- Osteogrycin B
- Vernamycin BA
- Vernamycin B alpha
- Pristinamycin P 1
- Pristinamycin P1
- Antibiotic PA 114B
- Antibiotic 899
- Vernamycin B.alpha.
- VERNAMYCIN B
- V50XJ0NC3I
- PRISTINAMYCIN 1A
- Antibiotic PA 114B1
- RefChem:389288
- MIKAMYCIN B [MI]
- Antibiotic PA 114 B1
- UNII-V50XJ0NC3I
- CHEBI:8417
- STREPTOGRAMIN B [MI]
- PRISTINAMYCIN IA [MI]
- PA 114B
- PA-114B
- NSC 92554
- VERNAMYCIN B, .ALPHA.
- CHEMBL1256399
- SCHEMBL13176900
- SCHEMBL29386427
- GTPL12934
- HY-A0279A
- NSC-92554
- VERNAMYCIN B.ALPHA. [MI]
- DTXSID701028335
- C45H54N8O10
- NSC92554
- ZINC9574677
- BBF-02584
- CS-5850
- BRN 0078387
- CID11136668
- 3131-03-1
- FP172927
- J20.721G
- X8445
- F85430
- 4-27-00-09718 (Beilstein Handbook Reference)
- A1025976
- Q14035740
- 4-(4-(Dimethylamino)-N-methyl-L-phenylalanine)virginiamycin S1
- 4-[4-(Dimethylamino)-N-methyl-L-phenylalanine]virginiamycin S1
- Virginiamycin S1, 4-(4(dimethylamino)-N-methyl-L-phenylalanine)-
- 270076-60-3
- N-((6R,9S,10R,13S,15aS,22S,24aS)-22-(4-(dimethylamino)benzyl)-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1]oxa[4,7,10,13,16]pentaazacyclononadecin-9-yl)-3-hydroxypicolinamide
- N-[(3S,6S,12R,15S,16R,19S,22S)-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
- Vernamycin Balpha; Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-
- N-((3-HYDROXY-2-PYRIDINYL)CARBONYL)-L-THREONYL-(2R)-2-AMINOBUTANOYL-L-PROLYL-4-(DIMETHYLAMINO)-N-METHYL-L-PHENYLALANYL-(2S)-4-OXO-2-PIPERIDINECARBONYL-(2S)-2-PHENYLGLYCINE (6->13)-LACTONE
- N-((3S,6S,12R,15S,16R,19S,22S)-3-((4-(dimethylamino)phenyl)methyl)-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo(20.4.0.06,10)hexacosan-15-yl)-3-hydroxypyridine-2-carboxamide
- N-(3-((4-(dimethylamino)phenyl)methyl)-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo(20.4.0.06,10)hexacosan-15-yl)-3-hydroxypyridine-2-carboxamide
- N-[(3-Hydroxy-2-pyridinyl)carbonyl]cyclo(L-Thr*-D-Abu-L-Pro-N-methyl-4-(dimethylamino)-L-Phe-4-oxo-L-2-piperidinecarbonyl-L-phenyl Gly-)
- N-[(3-Hydroxy-2-pyridyl)carbonyl]cyclo(L-Thr*-D-Abu-L-Pro-N-methyl-4-(dimethylamino)-L-Phe-4-oxo-L-2-piperidinecarbonyl-L-phenyl Gly-)
- N-[(3S,6S,12R,15S,16R,19S,22S)-3-{[4-(dimethylamino)phenyl]methyl}-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
- N-[(6R,9S,10R,13S,15aS,22S,24aS)-22-{[4-(dimethylamino)phenyl]methyl}-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxypyridine-2-carboxamide
- N-[3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide